Pharmaceutical & Biotech ROW articles
- Putting Early Access On The Radar: Peter Mansell talks to Simon Estcourt about Idis' expertise in early market access and innovating the pharma and biotech model, PharmaTimes - Apr 10
File size - 1.1MB - Benefits of pre-launch access: An overview by Natalie Douglas, CEO Idis - Jan 09
File size - 4.2MB - The Journal of Life Sciences - Aug/Sep 08
File size - 588KB - Meeting Unmet Needs: An overview by Natalie Douglas, CEO Idis - 2008
File size - 1.3MB